Will PayPal Stock Recover or Keep Sliding?
Payments platform behemoth PayPal Holdings, Inc. (NASDAQ:PYPL) is going through…
Sell
48
EVO Quote, Financials, Valuation and Earnings
Last price:
$4.0800
Seasonality move
:
12.86%
Day range:
$3.7700 - $3.9700
52-week range:
$2.8400 - $7.7700
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.63x
P/B ratio:
1.42x
Volume:
339.7K
Avg. volume:
116.3K
1-year change:
-46.06%
Market cap:
$1.4B
Revenue:
$862.6M
EPS (TTM):
-$0.53
Analysts' Opinion
-
Consensus RatingEvotec SE has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.5073, Evotec SE has an estimated upside of 63.91% from its current price of $3.9700.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.0061 representing 24.28% downside risk from its current price of $3.9700.
Fair Value
-
According to the consensus of 1 analyst, Evotec SE has 63.91% upside to fair value with a price target of $6.5073 per share.
EVO vs. S&P 500
-
Over the past 5 trading days, Evotec SE has overperformed the S&P 500 by 20.19% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Evotec SE does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Evotec SE has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Evotec SE reported revenues of $203.3M.
Earnings Growth
-
Evotec SE has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Evotec SE reported earnings per share of -$0.12.
Enterprise value:
1.5B
EV / Invested capital:
--
Price / LTM sales:
1.63x
EV / EBIT:
--
EV / Revenue:
1.69x
PEG ratio (5yr expected):
-0.05x
EV / Free cash flow:
-11.82x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$115.4M
Return On Assets:
-7.98%
Net Income Margin (TTM):
-22.02%
Return On Equity:
-15.99%
Return On Invested Capital:
-10.76%
Operating Margin:
-17.68%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $789.5M | $845.5M | $862M | $216.8M | $235.8M | |
| Gross Profit | $182.1M | $189.4M | $124M | $40.6M | $49.1M | |
| Operating Income | $21.4M | -$29.3M | -$86M | $4.5M | $8.7M | |
| EBITDA | -$150.7M | -$74.7M | -$197.4M | -$22.4M | -$12.2M | |
| Diluted EPS | -$0.53 | -$0.26 | -$0.60 | -$0.05 | -$0.12 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $810.4M | $1.2B | $1.2B | $998.4M | $709.6M | |
| Total Assets | $1.8B | $2.5B | $2.4B | $2.5B | $2B | |
| Current Liabilities | $256.4M | $367.4M | $362.2M | $513.5M | $358.6M | |
| Total Liabilities | $907.6M | $970.9M | $1.1B | $1.3B | $998.9M | |
| Total Equity | $891.1M | $1.6B | $1.3B | $1.2B | $991.2M | |
| Total Debt | $426.1M | $410.4M | $353.7M | $692.2M | $461.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $217M | $39.4M | $19.7M | $21.5M | $81.3M | |
| Cash From Investing | -$435.3M | -$14.4M | -$77M | -$32.6M | $19.9M | |
| Cash From Financing | -$61.3M | $77.9M | -$174.7M | $24.7M | -$29.4M | |
| Free Cash Flow | $25.8M | -$194.4M | -$123.4M | -$49.1M | $56M | |
EVO
Sector
Market Cap
$1.4B
$34.9M
Price % of 52-Week High
51.09%
42.85%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.82%
1-Year Price Total Return
-46.06%
-40.42%
Beta (5-Year)
1.692
0.738
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$3.4163
200-day SMA
Sell
Level
$4.0111
Bollinger Bands (100)
Sell
Level
3.5625 - 4.6425
Chaikin Money Flow
Sell
Level
-60.3M
20-day SMA
Buy
Level
$3.3170
Relative Strength Index (RSI14)
Buy
Level
65.2065
ADX Line
Buy
Level
25.5185
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$3.7352
MACD (12, 26)
Sell
Level
-0.0193
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Neutral
Level
15.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.7131)
Sell
CA Score
(Annual)
Level (-0.7226)
Buy
Beneish M-Score
(Annual)
Level (-2.6044)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (0.2906)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Stock Forecast FAQ
In the current month, EVO has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EVO average analyst price target in the past 3 months is $6.5073.
-
Where Will Evotec SE Stock Be In 1 Year?
According to analysts, the consensus estimate is that Evotec SE share price will rise to $6.5073 per share over the next 12 months.
-
What Do Analysts Say About Evotec SE?
Analysts are divided on their view about Evotec SE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Evotec SE is a Sell and believe this share price will drop from its current level to $3.0061.
-
What Is Evotec SE's Price Target?
The price target for Evotec SE over the next 1-year time period is forecast to be $6.5073 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is EVO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Evotec SE is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of EVO?
You can purchase shares of Evotec SE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Evotec SE shares.
-
What Is The Evotec SE Share Price Today?
Evotec SE was last trading at $4.0800 per share. This represents the most recent stock quote for Evotec SE. Yesterday, Evotec SE closed at $3.9700 per share.
-
How To Buy Evotec SE Stock Online?
In order to purchase Evotec SE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 34x
Alerts
Buy
56
ROOT alert for Apr 23
Root [ROOT] is up 8.82% over the past day.
Buy
72
EFX alert for Apr 23
Equifax [EFX] is up 2.03% over the past day.
Buy
51
CALX alert for Apr 23
Calix [CALX] is up 0.11% over the past day.
